Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 5:12:662777.
doi: 10.3389/fpsyg.2021.662777. eCollection 2021.

Psychological Burden and Psycho-Oncological Interventions for Patients With Hepatobiliary Cancers-A Systematic Review

Affiliations
Review

Psychological Burden and Psycho-Oncological Interventions for Patients With Hepatobiliary Cancers-A Systematic Review

Johanna Graf et al. Front Psychol. .

Abstract

Background: Worldwide, hepatobiliary cancers are frequent diseases and often accompanied by a poor prognosis. These cancers, with hepatocellular carcinoma (HCC) and cholangiocarcinoma (CHC) being the most frequent, are often associated with a considerable amount of psychological burden such as anxiety, depressiveness, and reduced health-related quality of life (HRQOL) which may lead to psychiatric comorbidities. This systematic review gives an overview on psychological burden and on the effectiveness of psycho-oncological interventions for patients with HCC and CHC.

Methods: The databases PubMed, PubPsych, and PsycINFO were used and searched using the following combination of terms: (Neoplasm OR Cancer OR Tumor OR Carcinoma) AND (Psycho-Oncology OR Psychotherapy OR Psychiatr) AND (Liver OR Hepatic OR Hepatocellular OR Gallbladder OR Bile). Studies were eligible for inclusion if investigating patients affected with tumors of the liver (HCC/CHC) and using diagnostic instruments to assess mental health symptoms and research concerning specific psycho-oncological interventions. In total, 1027 studies were screened by one author with regard to title and abstracts. Afterward, the two authors of the paper discussed inclusion of possible articles.

Results: Twelve studies focusing on distress, anxiety, and depression symptoms as well as quality of life among patients with HCC/CHC and three studies on psycho-oncological interventions were included. Patients suffering from hepatobiliary cancers often experience considerable psychological burden. A quarter of patients suffer from depressive symptoms; anxiety is even more common among these patients with almost 40%. The HRQOL of those affected is reduced in almost all areas, suicide rates increased and the level of distress is considerably increased in one third of patients even in comparison to those with other kinds of cancer. By psycho-oncological intervention the prevalence of depressive symptoms and anxiety can be reduced, while the quality of life and also the survival rate of patients with hepatobiliary cancer can be increased.

Discussion and conclusion: Psychological burden is high in patients with hepatobiliary cancers as reflected in high levels of depressiveness and anxiety as well as reduced quality of life. The use of psycho-oncological interventions can reduce psychological burden and increase quality of life compared to patients receiving standard support only.

Systematic review registration: (prospero), identifier (CRD42021243192).

Keywords: anxiety; depression; psycho-oncological intervention; psychotherapy; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Prisma flow chart.
FIGURE 2
FIGURE 2
Studies assessing the prevalence of depressiveness and anxiety in patients with hepatocellular carcinoma. Data for depressiveness (n = 799 patients) are based on Mikoshiba et al. (2013), Cheng et al. (2019), Jia et al. (2019), and Wang et al. (2019), for anxiety (n = 515 patients) on Liu et al. (2017), Jia et al. (2019), and Wang et al. (2019).
FIGURE 3
FIGURE 3
Studies assessing the effect of psycho-oncological interventions in patients with hepatobiliary cancers on depressiveness (A) and anxiety (B) [based on Steel et al. (2007) and Wang et al. (2019)].

References

    1. Anderson C., Park E. M., Rosenstein D. L., Nichols H. B. (2018). Suicide rates among patients with cancers of the digestive system. Psychooncology 27 2274–2280. 10.1002/pon.4827 - DOI - PMC - PubMed
    1. Benson A. B., D’Angelica M. I., Abbott D. E., Abrams T. A., Alberts S. R., Anaya D. A., et al. (2019). Guidelines insights: hepatobiliary cancers, Version 2.2019. J. Natl. Compr. Canc. Netw. 17 302–310. 10.6004/jnccn.2019.0019 - DOI - PubMed
    1. Chang C. H., Chen S. J., Liu C. Y. (2015). Risk of developing depressive disorders following hepatocellular carcinoma: a nationwide population-based study. PLoS One 10:e0135417. 10.1371/journal.pone.0135417 - DOI - PMC - PubMed
    1. Cheng C., Chan N. Y., Chio J. H., Chan P., Chan A. O., Hui W. M. (2012). Being active or flexible? Role of control coping on quality of life among patients with gastrointestinal cancer. Psychooncology 21 211–218. 10.1002/pon.1892 - DOI - PubMed
    1. Cheng H. H., Kamarck T. W., Gianaros P. J., Roecklein K. A., Vanegas Y., Tsung A., et al. (2019). Socioeconomic disparities of depressive symptoms and cytokines in hepatocellular carcinoma. Psychooncology 28 1624–1632. 10.1002/pon.5127 - DOI - PMC - PubMed

LinkOut - more resources